Algert Global LLC Biotechnology

Algert Global LLC

$4.77 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
AKRO Akero Therapeutics, Inc.	$2.23B	$1.17 Million 0.02% of portfolio	21,919	Q2 2025 Reduced 70.75%
ACAD Acadia Pharmaceuticals Inc	$4.12B	$1.15 Million 0.02% of portfolio	53,092	Q2 2025 Reduced 84.82%
XNCR Xencor Inc	$463M	$1.04 Million 0.02% of portfolio	132,045	Q2 2025 New
RCKT Rocket Pharmaceuticals, Inc.	$220M	$837,000 0.02% of portfolio	341,760	Q2 2025 Added 515.67%
ITOS I Teos Therapeutics, Inc.	$359M	$743,000 0.02% of portfolio	74,477	Q2 2025 Reduced 6.85%
KROS Keros Therapeutics, Inc.	$353M	$742,000 0.02% of portfolio	55,570	Q2 2025 Added 102.22%
REPL Replimune Group, Inc.	$259M	$737,000 0.02% of portfolio	79,370	Q2 2025 Added 73.22%
PTGX Protagonist Therapeutics, Inc	$2.68B	$722,000 0.02% of portfolio	13,055	Q2 2025 Reduced 30.06%
RCUS Arcus Biosciences, Inc.	$698M	$632,000 0.01% of portfolio	77,656	Q2 2025 Reduced 71.14%
KYMR Kymera Therapeutics, Inc.	$2.18B	$473,000 0.01% of portfolio	10,850	Q2 2025 New
INCY Incyte Corp	$18.2B	$460,000 0.01% of portfolio	6,760	Q2 2025 Reduced 83.0%
MDXG Mimedx Group, Inc.	$821M	$456,000 0.01% of portfolio	74,667	Q1 2025 Added 180.31%
EWTX Edgewise Therapeutics, Inc.	$846M	$455,000 0.01% of portfolio	34,723	Q2 2025 New
ASND Ascendis Pharma A/S	$10.9B	$375,000 0.01% of portfolio	2,175	Q2 2025 Reduced 14.67%
VERV Verve Therapeutics, Inc.	$667M	$361,000 0.01% of portfolio	32,185	Q2 2025 Reduced 75.03%
PRTA Prothena Corp Public LTD CO	$354M	$292,000 0.01% of portfolio	48,150	Q2 2025 New
QURE Uni Qure N.V.	$668M	$270,000 0.01% of portfolio	19,340	Q2 2025 New
VRDN Viridian Therapeutics, Inc.\De	$717M	$261,000 0.01% of portfolio	18,693	Q2 2025 Reduced 58.96%
REGN Regeneron Pharmaceuticals, Inc.	$59.7B	$239,000 0.01% of portfolio	456	Q2 2025 Added 0.44%
KRYS Krystal Biotech, Inc.	$3.69B	$206,000 0.0% of portfolio	1,500	Q2 2025 New
SVRA Savara Inc	$294M	$182,000 0.0% of portfolio	79,948	Q2 2025 Reduced 39.87%
WVE Wave Life Sciences Ltd.	$734M	$172,000 0.0% of portfolio	26,420	Q2 2025 New
RGNX Regenxbio Inc.	$350M	$166,000 0.0% of portfolio	20,248	Q2 2025 Reduced 59.16%
VTYX Ventyx Biosciences, Inc.	$149M	$153,000 0.0% of portfolio	71,560	Q2 2025 Added 170.14%
EYPT Eye Point Pharmaceuticals, Inc.	$366M	$126,000 0.0% of portfolio	13,340	Q2 2025 New
AVIR Atea Pharmaceuticals, Inc.	$292M	$110,000 0.0% of portfolio	30,639	Q1 2025 Added 11.83%
PLRX Pliant Therapeutics, Inc.	$81.8M	$103,000 0.0% of portfolio	88,690	Q1 2025 Reduced 17.58%
VIR Vir Biotechnology, Inc.	$578M	$100,000 0.0% of portfolio	19,802	Q4 2024 Reduced 90.72%
LRMR Larimar Therapeutics, Inc.	$160M	$84,000 0.0% of portfolio	29,030	Q2 2025 Added 24.7%
ALEC Alector, Inc.	$165M	$62,000 0.0% of portfolio	44,460	Q4 2024 Reduced 28.19%
MNKD Mannkind Corp	$942M	$58,000 0.0% of portfolio	15,480	Q2 2025 New
TCRX T Scan Therapeutics, Inc.	$31.6M	$41,000 0.0% of portfolio	28,030	Q2 2025 New
MRSN Mersana Therapeutics, Inc.	$590M	$30,000 0.0% of portfolio	101,313	Q2 2025 Reduced 24.96%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.